NCT03012932View on ClinicalTrials.gov

HPV Self-Sampling for Cervical Cancer Screening Among Lesbian, Bisexual, and Queer (LBQ) Women

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

February 2, 2017

Primary Completion Date

March 24, 2018

Study Completion Date

March 24, 2018

Conditions
Cervical Cancer Screening
Interventions
BEHAVIORAL

HPV self-sampling

All participants will receive HPV self-sampling intervention. HPV self-sampling is a cervical cancer screening that can be done in private, using a device that is similar to a tampon. This intervention tests for high-risk HPV, the primary cause of cervical cancer. Each participant will complete the intervention one time only.

Trial Locations (1)

33146

University of Miami, Miami

All Listed Sponsors
lead

University of Miami

OTHER

NCT03012932 - HPV Self-Sampling for Cervical Cancer Screening Among Lesbian, Bisexual, and Queer (LBQ) Women | Biotech Hunter | Biotech Hunter